a

FDA Approves Generic Form of Lyrica

Written by  Taryn Tawoda | July 11, 2012
Social sharing
The FDA has approved a generic form of the neuropathic pain drug Lyrica, according to MedPage Today report.
Lupin, based in India, has been granted approval to manufacture eight oral strengths of the generic formulation.

Related Articles on Pain Management:

myoscience Receives FDA Clearance for Pain Management Device
Pain Management Specialist Dr. John Keel Joins New England Baptist Hospital
Opposition Threatens Kentucky Drug Abuse Bill
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.

blog comments powered by Disqus